Pritzker Private Capital has acquired KabaFusion, a provider of acute and specialty home infusion services.
KabaFusion operates seven fully accredited specialty pharmacies located in California, Florida, Illinois, Massachusetts, New Jersey, Pennsylvania and Texas and serves patients with a range of acute and chronic conditions in more than 40 states, specializing in intravenous immunoglobulin (IVIG) and other infusion therapies. KabaFusion was founded by Dr. Sohail Masood and is headquartered in Cerritos, CA (www.KabaFusion.com).
Pritzker Private Capital is investing alongside KabaFusion’s pharmacist-led management team, who will continue to lead the business. “We are committed to providing our patients with the highest quality of specialty home infusion treatments and are thrilled to partner with Pritzker Private Capital,” said Dr. Masood, KabaFusion’s CEO. “We selected Pritzker Private Capital because of their deep experience in healthcare services and differentiated long-term approach to building world-class businesses.”
“KabaFusion is a great example of a clinician-led company that puts patient care first,” said Tony Pritzker, Chairman and CEO of Pritzker Private Capital. “KabaFusion’s exceptional leadership team has decades of experience serving patients. Their commitment to excellence perfectly aligns with our core values.”
PPC Partners acquires North America-based middle-market companies that have enterprise values between $100 million and $750 million and EBITDA in excess of $15 million. Sectors of interest include manufactured products, services and healthcare.
“KabaFusion is a leader in IVIG and home infusion due to its patient-focused service model and clinical expertise,” said Michael Dal Bello, an investment partner at Pritzker Private Capital. “We are delighted to partner with Dr. Masood and the KabaFusion management team and look forward to supporting the company’s continued growth.”
PPC Partners is led by Tony Pritzker and the former investment and operating professionals of Pritzker Group Private Capital. In July 2018, PPC Partners held a final closing of PPC Fund II LP at its hard cap of $1.8 billion. PPC Partners has offices in Chicago and Los Angeles (www.PPCPartners.com).
What does this transaction mean for the strategic options for your healthcare business?
Contact Paragon Ventures for more information. https://www.paragonventures.com 800-719-1555
Paragon Ventures is a leading specialist in strategic transactions including the merger and acquisition of private mid-market healthcare companies. Celebrating its 25th year in business, Paragon Ventures has advised thousands of healthcare business owners and successfully closed over 240 strategic healthcare transactions.
